Canada Authorizes First-Ever Oral Treatment for Postpartum Depression
Canada approves ZURZUVAE, the first oral PPD pill. This breakthrough 14-day oral therapy aims to elevate the standard of maternal mental health care.
Maternal Mental Health: New Study Supports Expanding Ways To Get Help
One in five Canadian pregnant and postpartum women experience depression and anxiety, but fewer than 10% receive proper treatment. A new study shows effective ways to expand access.
Revolutionary Peer-Led Online Therapy: A Game-Changer for Postpartum Depression Treatment
A groundbreaking study found that CBT delivered by mothers who have recovered from PPD is 11 times more effective than when delivered by a therapist.